HP and cancer: Motivated by the use of antibody-drug conjugates (ADCs) that have been used to treat cancer, research from MacGregor et al. showed that an experimental T. brucei infection could be cured with a single dose of an antibody targeting the haptoglobin-hemoglobin receptor conjugated to the toxin pyrrolobenzodiazepine (27).